Cargando…
Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy
BACKGROUND: Organ-preserving chemo-radiotherapy (CRT) is the standard of care for non-metastatic anal squamous cell carcinoma (SCC). The optimal dosing schedules are yet to be determined. To improve local control rates, dose escalation has been investigated but found to not increase efficacy at the...
Autores principales: | Jones, Michael, Hruby, George, Stanwell, Peter, Gallagher, Sarah, Wong, Karen, Arm, Jameen, Martin, Jarad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423099/ https://www.ncbi.nlm.nih.gov/pubmed/25885556 http://dx.doi.org/10.1186/s12885-015-1244-7 |
Ejemplares similares
-
Investigation on the performance of dedicated radiotherapy positioning devices for MR scanning for prostate planning
por: Sun, Jidi, et al.
Publicado: (2015) -
IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
por: De Felice, Francesca, et al.
Publicado: (2023) -
FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial
por: Jones, Michael Peter, et al.
Publicado: (2019) -
Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013) -
Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
por: Charnley, N, et al.
Publicado: (2005)